Johnson & Johnson preparing to seek approval of its Covid-19 vaccine
Washington, Jan 29 (EFE).- Johnson & Johnson said Friday that its prospective Covid-19 vaccine has proven 66 percent effective in protecting against moderate to severe coronavirus and 85 percent...